Home > EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl).

European Monitoring Centre for Drugs and Drug Addiction, Europol. [EMCDDA] (2018) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl). Luxembourg: Publications Office of the European Union. 16 p.

[img]
Preview
PDF (Cyclopropylfentanyl)
323kB

In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 19 December 2017.


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Opioid, New psychoactive substance
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:February 2018
Pages:16 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction, Europol
Place of Publication:Luxembourg
EndNote:View
Related URLs:
Subjects:B Substances > Opioids (opiates)
B Substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page